Nalaganje...
Overview: Progression-Free Survival as an Endpoint in Clinical Trials with Solid Tumors
Progression-free survival (PFS) is increasingly used as an important and even a primary endpoint in randomized cancer clinical trials in the evaluation of patients with solid tumors, because of both practical and clinical considerations. Although in its simplest form PFS is the time from randomizati...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654394/ https://ncbi.nlm.nih.gov/pubmed/23669420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2934 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|